We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

20 Mar 2019 07:00

RNS Number : 3621T
Instem plc
20 March 2019
 

20 March 2019

Instem plc

 

("Instem" or the "Company")

 

Notice of Results

 

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, will announce full year results for the year ended 31 December 2018 on Monday 1 April 2019.

 

Analyst Presentation

Management will be hosting a presentation on the day of the results at 10.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD. Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.

 

Investor Presentation

The Company will also be hosting a presentation for investors in London on Tuesday 2 April 2019. Phil Reason, CEO of the Company will present financial and operational results for the year ended 31 December 2018, as well as an overview of the Company and its plans for the future.

 

The event is open to all investors and will be held from 16.30 for a 16.45 start at a venue in the City. To register for the event, please email instem@walbrookpr.com or call the Walbrook PR team, below.

 

 

For further information, please contact:

 

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

Nigel Goldsmith, CFO

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Richard Lindley

Rachel Hayes

Walbrook Financial PR

+44 (0) 20 7933 8780

Paul Cornelius

instem@walbrookpr.com

Nick Rome

Sam Allen

 

 

About Instem

 

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit instem.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORFMGMFNLVGLZM
Date   Source Headline
21st Nov 20237:00 amRNSCancellation - Instem Plc
21st Nov 20237:00 amRNSCancellation of admission to trading
20th Nov 202312:33 pmRNSScheme becomes Effective
20th Nov 20237:30 amRNSSuspension - Instem PLC
17th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
16th Nov 20233:23 pmRNSIssuance of Shares following Court Sanction
16th Nov 20232:30 pmRNSCourt Sanction of the Scheme
16th Nov 202310:02 amRNSForm 8.5 (EPT/RI)
15th Nov 20231:40 pmPRNForm 8.3 - Instem Plc
15th Nov 202310:16 amRNSForm 8.5 (EPT/RI)
14th Nov 20235:30 pmRNSInstem
14th Nov 20233:01 pmGNWForm 8.3 - Instem plc
14th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
14th Nov 202311:08 amRNSForm 8.5 (EPT/RI)
14th Nov 202310:19 amRNSForm 8.3 - Instem Plc
13th Nov 20232:30 pmPRNForm 8.3 - Instem Plc
13th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
13th Nov 202310:03 amRNSForm 8.5 (EPT/RI) - Instem plc
13th Nov 202310:00 amRNSForm 8.3 - Instem Plc
10th Nov 20233:14 pmPRNForm 8.3 - Instem Plc
10th Nov 202312:03 pmGNWForm 8.3 - Instem plc
10th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
10th Nov 202310:24 amRNSForm 8.3 - Instem Plc
9th Nov 20233:27 pmRNSForm 8.3 - Instem PLC
9th Nov 20231:42 pmPRNForm 8.3 - Instem Plc
9th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
9th Nov 202310:17 amRNSForm 8.3 - Instem Plc
8th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
7th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
7th Nov 202311:40 amRNSForm 8.5 (EPT/RI)
7th Nov 20237:00 amRNSSatisfaction of Conditions
6th Nov 20234:28 pmRNSForm 8.3 - INSTEM PLC (replaces RNS 5325S &5364S)
6th Nov 20234:00 pmRNSForm 8.3 - INSTEM PLC (cancel & replace RNS5325)
6th Nov 20233:05 pmRNSForm 8.3 - INSTEM PLC
6th Nov 20233:00 pmRNSForm 8.3 - Instem PLC
6th Nov 20232:10 pmGNWForm 8.3 - Instem Plc
6th Nov 20231:30 pmPRNForm 8.3 - Instem Plc
6th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
3rd Nov 20235:56 pmRNSHolding(s) in Company
3rd Nov 20231:52 pmPRNForm 8.3 - Instem Plc
3rd Nov 20231:39 pmRNSHolding(s) in Company
3rd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
3rd Nov 20239:49 amRNSForm 8.5 (EPT/RI)
3rd Nov 20237:05 amRNSForm 8.3 - Instem plc
2nd Nov 20232:25 pmRNSResults of Court Meeting and General Meeting
31st Oct 20239:39 amRNSForm 8.5 (EPT/RI)
30th Oct 202310:09 amRNSForm 8.5 (EPT/RI)
30th Oct 20237:00 amRNSOffer Update
27th Oct 20233:00 pmBUSForm 8.3 - INS LN
27th Oct 20231:09 pmGNWForm 8.3 - Instem Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.